In The News,
Medicare Home Infusion Therapy Benefit
Developed a model to analyze the Medicare spending impact resulting from legislation that would explicitly provide home infusion therapy benefit coverage for certain Part B drugs. Analysis was used to bolster the manufacturer’s congressional lobbying efforts, and was presented as ready-made advocacy materials.